SageView Advisory Group’s Cellectis CLLS Stock Holding History

SageView Advisory Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$557	Buy	+115	New	+$481	﹤0.01%	2438

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SageView Advisory Group's CLLS Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Cellectis (CLLS) in Q4 2025: 115 shares worth $557. The stake represents ﹤0.01% of the portfolio and ranks #2438 among its holdings.

34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.

SageView Advisory Group held 115 shares of Cellectis worth $557 as of Q4 2025.
Cellectis was a new SageView Advisory Group position in Q4 2025.
Cellectis made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2438 holding.
34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.